复发难治弥漫大B细胞淋巴瘤自体造血干细胞移植后利妥昔单抗维持治疗的价值评价

摘要

1文献来源 Gisselbrecht C, Schmitz N, Mounier N, et al. Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20^＋ diffuse large B-cell lymphoma： Final analysis of the collaborative trial in relapsed aggressive lymphoma [J]. J Clin Oncol, 2012, 30（36）： 4462-4469.